miltefosine has been researched along with Liver Diseases in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Liver Diseases: Pathological processes of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, SK | 1 |
| Sinha, PK | 1 |
| Sundar, S | 1 |
| Thakur, CP | 1 |
| Jha, TK | 1 |
| Pandey, K | 1 |
| Das, VR | 1 |
| Kumar, N | 1 |
| Lal, C | 1 |
| Verma, N | 1 |
| Singh, VP | 1 |
| Ranjan, A | 1 |
| Verma, RB | 1 |
| Anders, G | 1 |
| Sindermann, H | 1 |
| Ganguly, NK | 1 |
1 trial available for miltefosine and Liver Diseases
| Article | Year |
|---|---|
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Antiprotozoal Agents; Aspartate | 2007 |